BioNTech SE (BNTX)
BioNTech SE has a market cap or net worth of $71.52 billion. The enterprise value is $70.30 billion.
The next estimated earnings date is Nov 9, 2021, which is a Tuesday.
|Estimated Earnings Date||Nov 9, 2021|
BioNTech SE has 242.52 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||1.16%|
|Owned by Institutions (%)||16.59%|
The trailing PE ratio is 16.40 and the forward PE ratio is 6.13. BioNTech SE's PEG ratio is 0.05.
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||3,793.08|
|EV / Sales||119.52|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.25.
|Debt / Equity||0.25|
|Debt / EBITDA||-8.21|
|Debt / FCF||-3.54|
Return on equity (ROE) is 1.60%, which is considered low. The company has a ROIC of -19.70%.
|Return on Equity (ROE)||1.60%|
|Return on Assets (ROA)||1.00%|
|Return on Capital (ROIC)||-19.70%|
|Revenue Per Employee||$235,280|
|Profits Per Employee||$7,414|
|Effective Tax Rate||110.42%|
Stock Price Statistics
The stock price has increased by +213.83% in the last 52 weeks. The beta is -1.16, so BioNTech SE's price volatility has been lower than the market average.
|52-Week Price Change||+213.83%|
|50-Day Moving Average||295.51|
|200-Day Moving Average||258.86|
|Average Volume (30 Days)||2,814,609|
Short Selling Information
|Short % of Shares Out||0.94%|
|Short % of Float||2.94%|
|Short Ratio (days to cover)||0.71|
In the last 12 months, BioNTech SE had revenue of 588.20 million and earned 18.53 million in profits. Earnings per share was $17.99.
|Earnings Per Share (EPS)||$17.99|
The company has $1.64 billion in cash and $421.63 million in debt, giving a net cash position of $1.22 billion or $5.04 per share.
|Cash & Cash Equivalents||1.64B|
|Net Cash Per Share||$5.04|
|Book Value Per Share||6.90|
In the last 12 months, operating cash flow was -$16.43 million and capital expenditures -$102.69 million, giving a free cash flow of -$119.12 million.
|Operating Cash Flow||-16.43M|
|Free Cash Flow||-119.12M|
|FCF Per Share||-$0.49|
Gross margin is 87.70%, with operating and profit margins of -17.09% and 3.15%.
Dividends & Yields
BioNTech SE does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|